Innovative Patient Solutions. Value That Matters.

Learn more about our portfolio of innovative therapies by visiting the product pages.

Product Pipeline

Our advanced science, patented technologies, and innovative approach to drug discovery and development has allowed us to create and commercialize a portfolio of products that aim to advance the standard of care for acute care and oncology patients.

SUSTOL® for Chemotherapy-Induced Nausea and Vomiting Prevention (CINV):
U.S. FDA approved as a subcutaneous injection

U.S. FDA approved as both a 30-minute intravenous (IV) infusion and a 2-minute IV injection

ZYNRELEF® for Postoperative Pain Management:
Approved in the U.S., Canada and 31 European Countries

APONVIE for Postoperative Nausea and Vomiting (PONV):
U.S. FDA approved as a 30-second IV injection of aprepitant for PONV

Sign-Up for Email Updates

Receive news and updates on Heron’s latest innovations.

Dev Tool:

Request: product-portfolio
Matched Rewrite Rule: (.?.+?)(?:/([0-9]+))?/?$
Matched Rewrite Query: pagename=product-portfolio&page=
Loaded Template: page.php